Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Oscar Health Inc’s stock clocked out at $14.7, up 7.93% from its previous closing price of $13.62. In other words, the price has increased by $7.93 from its previous closing price. On the day, 81.14 million shares were traded. OSCR stock price reached its highest trading level at $15.045 during the session, while it also had its lowest trading level at $12.86.
Ratios:
To gain a deeper understanding of OSCR’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On July 14, 2025, Piper Sandler Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $14.
Wells Fargo Downgraded its Equal Weight to Underweight on July 11, 2025, while the target price for the stock was maintained at $10.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 20 ’25 when RANMALI BOPITIYA bought 30,000 shares for $18.77 per share.
ALESSANDREA QUANE bought 148,280 shares of OSCR for $2,598,488 on May 16 ’25. On May 12 ’25, another insider, Robinson Elbert O. Jr., who serves as the Director of the company, sold 25,000 shares for $16.43 each. As a result, the insider received 410,750 and left with 64,512 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 3743751680 and an Enterprise Value of 838518464. As of this moment, Oscar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 52.76, and their Forward P/E ratio for the next fiscal year is 168.91. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.37 while its Price-to-Book (P/B) ratio in mrq is 2.80. Its current Enterprise Value per Revenue stands at 0.083 whereas that against EBITDA is 4.195.
Stock Price History:
The Beta on a monthly basis for OSCR is 1.88, which has changed by -0.0754717 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, OSCR has reached a high of $23.79, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -8.93%, while the 200-Day Moving Average is calculated to be -3.80%.
Shares Statistics:
It appears that OSCR traded 19.96M shares on average per day over the past three months and 46362500 shares per day over the past ten days. A total of 217.98M shares are outstanding, with a floating share count of 180.17M. Insiders hold about 29.26% of the company’s shares, while institutions hold 61.79% stake in the company. Shares short for OSCR as of 1751241600 were 28587987 with a Short Ratio of 1.43, compared to 1748563200 on 21603388. Therefore, it implies a Short% of Shares Outstanding of 28587987 and a Short% of Float of 14.530000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A comprehensive evaluation of Oscar Health Inc (OSCR) is underway, with the input of 3.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.13 and low estimates of -$0.24.
Analysts are recommending an EPS of between $0.84 and $0.02 for the fiscal current year, implying an average EPS of $0.5. EPS for the following year is $0.75, with 5.0 analysts recommending between $1.88 and $0.19.
Revenue Estimates
In the current quarter, 6 analysts expect revenue to total $2.97B. It ranges from a high estimate of $3.08B to a low estimate of $2.9B. As of the current estimate, Oscar Health Inc’s year-ago sales were $2.22BFor the next quarter, 6 analysts are estimating revenue of $2.91B. There is a high estimate of $3.15B for the next quarter, whereas the lowest estimate is $2.74B.
A total of 6 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $12.1B, while the lowest revenue estimate was $11.27B, resulting in an average revenue estimate of $11.68B. In the same quarter a year ago, actual revenue was $9.18BBased on 8 analysts’ estimates, the company’s revenue will be $11.23B in the next fiscal year. The high estimate is $12.69B and the low estimate is $9.37B.
